Siga Technologies (SIGA) Non-Current Assets (2010 - 2025)
Siga Technologies (SIGA) posted Non-Current Assets of $6.6 million for Q4 2025, up 71.36% on a QoQ basis from $3.9 million in Q3 2025, and down 50.27% year-over-year from $13.3 million in Q4 2024.
Siga Technologies (SIGA) Non-Current Assets (2010 - 2025) Analysis & Trends
Siga Technologies' Non-Current Assets history runs 16 years deep, the most recent figure standing at $6.6 million for Q4 2025.
- Quarterly Non-Current Assets fell 50.27% year-over-year to $6.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $30.0 million (down 49.42% YoY) and the FY2025 annual result came in at $6.6 million, down 50.27% from the prior year.
- Non-Current Assets was $6.6 million for Q4 2025 at Siga Technologies, up from $3.9 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $16.2 million in Q2 2024 and bottomed at $3.9 million in Q3 2025.
- A 5-year average of $9.8 million and a median of $8.3 million in 2022 frame the typical range for Non-Current Assets.
- Annual changes were most pronounced in 2023 — Non-Current Assets soared 93.94% — and 2025, when it slumped 73.7%.
- Siga Technologies' Non-Current Assets stood at $6.0 million in 2021, then soared by 54.84% to $9.2 million in 2022, then jumped by 66.08% to $15.4 million in 2023, then fell by 13.47% to $13.3 million in 2024, then tumbled by 50.27% to $6.6 million in 2025.
- Business Quant data shows SIGA's Non-Current Assets at $6.6 million in Q4 2025, $3.9 million in Q3 2025, and $6.1 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 36.78 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 26.33 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 8.68 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 79.20 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 3.84 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 15.70 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 25.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.47 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 9.64 Bn |
| 10 | Siga Technologies | 225.56 Mn | 70.59 Mn | - | 6.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.61 Mn |
| Sep 30, 2025 | 3.86 Mn |
| Jun 30, 2025 | 6.13 Mn |
| Mar 31, 2025 | 13.45 Mn |
| Dec 31, 2024 | 13.29 Mn |
| Sep 30, 2024 | 14.67 Mn |
| Jun 30, 2024 | 16.18 Mn |
| Mar 31, 2024 | 15.25 Mn |
| Dec 31, 2023 | 15.36 Mn |
| Sep 30, 2023 | 12.41 Mn |
| Jun 30, 2023 | 12.21 Mn |
| Mar 31, 2023 | 11.39 Mn |
| Dec 31, 2022 | 9.25 Mn |
| Sep 30, 2022 | 7.32 Mn |
| Jun 30, 2022 | 6.30 Mn |
| Mar 31, 2022 | 7.44 Mn |
| Dec 31, 2021 | 5.97 Mn |
| Sep 30, 2021 | 6.63 Mn |
| Jun 30, 2021 | 6.62 Mn |
| Mar 31, 2021 | 5.88 Mn |